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Abstract
Bacterial genome is characterized by frequent unmethylated cytosine-phosphate-guanine (CpG)
motifs. Deleterious effects can occur when synthetic oligodeoxynucleotides (ODN) with
unmethylated CpG dinucleotides (CpG-ODN) are administered in a systemic fashion. We aimed
to evaluate the effect of intratracheal CpG-ODN on lung inflammation and systemic inflammatory
response. C57BL/6J mice received intratracheal administration of CpG-ODN (0.01, 0.1, 1.0, 10, or
100 μM) or control ODN without CpG motif. Bronchoalveolar lavage (BAL) fluid was obtained 3
or 6 h or 1, 2, 7, or 14 days after the instillation and subjected to a differential cell count and
cytokine measurement. Lung permeability was evaluated as the BAL fluid-to-plasma ratio of the
concentration of human serum albumin that was injected 1 h before euthanasia. Nuclear factor
(NF)-κB DNA binding activity was also evaluated in lung homogenates. Intratracheal administration
of 10 μM or higher concentration of CpG-ODN induced significant inflammatory cell accumulation
into the airspace. The peak accumulation of neutrophils and lymphocytes occurred 1 and 2 days
after the CpG-ODN administration, respectively. Lung permeability was increased 1 day after the
10  μM CpG-ODN challenge. CpG-ODN also induced nuclear translocation of NF-κB and
upregulation of various inflammatory cytokines in BAL fluid and plasma. Histopathology of the lungs
and liver revealed acute lung injury and liver damage with necrosis, respectively. Control ODN
without CpG motif did not induce any inflammatory change. Since intratracheal CpG-ODN
induced acute lung injury as well as systemic inflammatory response, therapeutic strategies to
neutralize bacterial DNA that is released after administration of bactericidal agents should be
considered.
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Background
Acute respiratory distress syndrome (ARDS), which is the
most severe form of acute lung injury (ALI), is a critical ill-
ness with high mortality. ALI/ARDS may occur in associa-
tion with direct lung injury, including pneumonia,
aspiration of gastric contents, and inhalation of noxious
gas, or indirect lung injury, such as sepsis, blood transfu-
sions and shock. Among the various predisposing factors,
severe pneumonia is one of the most common causes [1].
Intratracheal administration of endotoxin (lipopolysac-
charide; LPS), which is a cell wall component of gram-
negative bacteria, has been extensively used as an experi-
mental model of ALI/ARDS following severe pneumonia
[2]. However, the roles of other bacterial components,
such as genomic DNA, in the development of lung injury
and systemic inflammatory response remain to be deter-
mined.
The bacterial genome, compared to vertebrate DNA, con-
tains a higher frequency of unmethylated cytosine-phos-
phate-guanine (CpG) dinucleotides. Small
oligodeoxynucleotides (ODN) with unmethylated CpG
dinucleotides (CpG-ODN) are able to mimic the immu-
nostimulatory activity of bacterial DNA since bacterial
DNA and synthetic ODN share similar base sequences
and bind to the same receptor system [3-5].
Toll-like receptors (TLRs) have been shown to play an
essential role in the activation of innate immunity by rec-
ognizing specific patterns of microbial components [6].
Among the TLRs, TLR9 recognizes bacterial or viral DNA,
although it is now known that TLR9 also recognizes
unmethylated CpG-containing DNA sequences, including
those of mammalian origin and synthetic ODN [4,7]. In
the lung, constitutive expression of TLR9 has been
detected in endothelial cells and macrophages [8,9]. It
was reported that intraperitoneal or intratracheal admin-
istration of CpG-ODN causes lung inflammation [10-12].
However, little is known regarding the lung permeability
changes, time course of the cytokine levels, and systemic
effects of intratracheal CpG-ODN challenge.
In this study, we evaluated inflammatory cell accumula-
tion and edema formation following intratracheal admin-
istration of CpG-ODN. Histopathology of the lungs and
the liver was also analyzed. Cytokine levels in plasma and
bronchoalveolar lavage (BAL) fluid were examined at var-
ious time points after CpG-ODN administration. Nuclear
factor (NF)-κB DNA binding activity was evaluated using
lung homogenates.
Methods
Materials
Synthetic CpG-ODN (5'-tccatgacgttcctgatgct-3') and con-
trol ODN without CpG motifs (5'-gcttgatgactcagccggaa-3')
were purchased from HyCult Biotechnology (Uden, The
Netherlands).
Mice
Eight-week old male C57BL/6J mice were obtained from
Charles River Laboratories Japan (Yokohama, Japan).
Mice were given free access to water and standard rodent
chow and were housed in pathogen-free cages. All animal
experiments were approved by the Animal Care and Use
Committee of Keio University School of Medicine.
Murine Model of Lung Injury
Lung injury was evaluated inflammatory cell accumula-
tion and edema formation in the lung as well as pathol-
ogy. Mice (20-25 g) were anesthetized with
intraperitoneal ketamine (120 mg/kg) and xylazine (12
mg/kg). Intratracheal instillation of CpG-ODN, control
ODN, or vehicle (phosphate buffered saline; PBS) in a
volume of 100 μL was performed via a Microsprayer (Pen-
nCentury, Philadelphia, PA). All mice were sacrificed by
deep anesthesia 3 or 6 h or 1, 2, 7 or 14 days after the
instillation.
Bronchoalveolar Lavage
The mice were anesthetized using intraperitoneal pento-
barbital sodium (50 mg/kg) and euthanized. The trachea
was exposed, and a 20-gauge angiocatheter was inserted
and secured. The lungs were lavaged with two separate
0.7-mL volumes of ice-cold PBS. The bronchoalveolar lav-
age (BAL) fluid was centrifuged at 400 × g for 10 min at
4°C to pellet the cell fraction, and the supernatant was
stored at -80°C until the measurements of the cytokines
and human serum albumin levels to calculate the perme-
ability index. The cell pellet was resuspended in 400 μL of
cold saline, and the total cell counts were determined
using a hemacytometer. Differential cell counts were per-
formed using cytocentrifuge smears stained with Diff-
Quik (Sysmex, Kobe, Japan).
Measurement of Proinflammatory Mediators in 
Bronchoalveolar Lavage Fluid and Plasma
BAL fluid and plasma were assayed for interleukin (IL)-1β,
TNF-α, IL-6, IL-10, IL-12p40, interferon-γ (IFN-γ), mono-
cyte chemoattractant protein-1 (MCP-1), macrophage
inflammatory protein-1α (MIP-1α), MIP-1β, and kerati-
nocyte-derived chemokine (KC) using a multiplex
cytokine bead array system (Bio-Plex™; Bio-Rad, Hercules,
CA) according to the manufacturer's instructions. In brief,
BAL fluid supernatants or plasma were incubated with
microbeads labeled with specific antibodies to one of the
above-mentioned cytokines for 30 min. Samples were
washed after the incubation and were then incubated with
the detection antibody cocktail, each antibody specific to
a single cytokine. This step was followed by another wash
step, and the beads were incubated with streptavidin-phy-
coerythrin for 10 min, washed again, and the concentra-Respiratory Research 2009, 10:84 http://respiratory-research.com/content/10/1/84
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tion of each cytokine was determined using the array
reader. The data were analyzed using the Bio-Plex™ Man-
ager software program.
Lung Permeability Index
Mice were given 10 mg/kg of human serum albumin
(HSA) dissolved in 100 μL of saline intravenously, 1 h
before euthanasia. At the time of sacrifice, the blood was
drawn from the inferior vena cava. The permeability index
was defined as the ratio of the HSA concentration in the
BAL fluid to that in the plasma, presented as a percentage
[13]. The HSA concentration was measured using an
immunoassay with a Human Albumin ELISA Quantita-
tion Kit (Bethyl Laboratories, Montgomery, TX). The
lower limit of detection was 5 ng/mL.
Histopathology of the Lungs and the Liver
In another series of experiments, the lungs were sampled
24 h after intratracheal instillation, fixed by intratracheal
instillation of 10% neutral phosphate-buffered formalin
at a pressure of 22 cm H2O and embedded in paraffin. The
liver was also fixed with 10% neutral phosphate-buffered
formalin and embedded in paraffin. The tissues were cut
into 3-μm sections and stained with hematoxylin-eosin
for pathology.
NF-κB (p65) DNA-binding Activity in the Lung
Nuclear protein extraction
After performing BAL, the left lungs were harvested and
snap frozen in liquid nitrogen and then stored at -80°C
until analysis. The lungs were homogenized in 2 mL of
ice-cold Buffer A (10 mM HEPES, 1.5 mM MgCl2, 10 mM
KCl, 0.5 mM DTT, 0.5 mM PMSF) with a 0.1% volume of
Nonidet P-40 and a protease inhibitor cocktail (1 mg/mL
leupeptin, 1 mg/mL aprotinin, 10 mg/mL soy bean
trypsin inhibitor, 1 mg/mL pepstain). Following 10 min
of incubation on ice, the homogenates were centrifuged at
850 × g for 10 min at 4°C. The pellets were resuspended
in 2 mL of Buffer A and centrifuged at 1,200 × g for 10 min
at 4°C. The crude nuclear pellets were resuspended in 40
mL of Buffer B (20 mM HEPES, 1.5 mM MgCl2, 0.42 M
NaCl, 0.2 mM EDTA, 25% vol/vol glycerol, 0.5 mM DTT,
0.5 mM PMSF) with a protease inhibitor cocktail (as
described above) and incubated for 30 min on ice.
Nuclear extracts were recovered following centrifugation
at 20,000 × g for 15 min at 4°C and stored at -80°C. The
protein concentration of the nuclear extracts was deter-
mined using a BCA Protein Assay Kit (Pierce, Rockford,
IL) with bovine serum albumin used as a standard.
NF-κB (p65) DNA-binding activity assay
NF-κB (p65) DNA-binding activity was examined using
the TransAM™ ELISA kit (Active Motif, Carlsbad, CA)
according to the manufacturer's protocol. In brief, 0.5 μg
of nuclear extract was subjected to the binding of NF-κB
to an immobilized consensus sequence (5'-GGGACTT-
TCC-3') in a 96-well plate, and the primary and secondary
antibodies were added. After the colorimetric reaction, the
samples were measured in a spectrophotometer at the
wavelength of 450 nm. Recombinant NF-κB p65 (Active
Motif) was used as a protein standard. The DNA binding
specificity was assessed using wild-type or mutated oligo-
nucleotides.
Statistical Analysis
Data are reported as mean ± SEM. Differences among
groups were determined using analysis of variance fol-
lowed by post hoc analysis with the Bonferroni's test for
multiple comparisons. A p value less than 0.05 was con-
sidered statistically significant.
Results
Accumulation of Inflammatory Cells after Intratracheal 
CpG-ODN Challenge
In the first series of experiments, mice received intratra-
cheal instillation of CpG-ODN (0.01, 0.1, 1.0, 10, or 100
μM) or vehicle. Two days later, BAL fluid was obtained to
evaluate inflammatory cell accumulation into the airspace
(Figure 1). There were no significant differences in the cell
counts between the PBS control animals and the mice
treated with 0.01, 0.1, or 1.0 μM of CpG-ODN. The higher
concentrations (10 and 100 μM) of CpG-ODN caused sig-
nificant increases in the cell counts in BAL fluid compared
Dose-response relationship of intratracheal CpG-ODN Figure 1
Dose-response relationship of intratracheal CpG-
ODN. Inflammatory cell recruitment into the alveolar space 
was evaluated after intratracheal challenge of CpG-ODN 
(0.01, 0.1, 1.0, 10, or 100 μM) or vehicle (n = 6 for each 
group) or vehicle. Two days later, BAL fluid was obtained 
and subjected to a cell count. Significant inflammatory cell 
accumulation into the airspace was observed in the mice that 
received 10 μM or higher concentration of CpG-ODN. Val-
ues are the mean ± SEM; n = 5-6 for each group. *p < 0.05 
compared with the PBS group. †p < 0.05 compared with the 
control ODN group.Respiratory Research 2009, 10:84 http://respiratory-research.com/content/10/1/84
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with the PBS control animals (p < 0.05). Since we
observed significant inflammatory cell accumulation into
the airspace in the mice that received 10 μM or higher con-
centration of CpG-ODN, we used 10 μM of CpG-ODN in
the following experiments.
In the next series, mice received intratracheal instillation
of CpG-ODN (10 μM); 6 h or 1, 2, 7, or 14 days later, BAL
fluid was obtained and used to perform a differential cell
count. We also collected BAL fluid 24 h after the instilla-
tion of control ODN or PBS. The total and differential cell
counts in BAL fluid are shown in Figure 2. CpG-ODN
instillation induced a significant increase in inflammatory
cell recruitment into the alveolar space, compared with
the instillation of control ODN or PBS (Figure 2A). On
day 1, the total cell count in BAL fluid was significantly
increased compared with the control ODN and the PBS
groups (p < 0.05). The total cell count was further
increased on day 2 and then decreased by day 14. There
was no difference in the total cell count in BAL fluid
between the control ODN and the PBS groups. Neutrophil
counts in BAL fluid were also markedly increased follow-
ing CpG-ODN challenge (Figure 2B). On days 1 and 2, the
neutrophil counts were significantly greater than in the
animals treated with the control ODN or PBS (p < 0.01).
The neutrophil counts then returned to the baseline by
day 7. As shown in Figure 2C, lymphocyte counts in BAL
fluid were significantly increased on days 2 and 7 com-
pared with the control groups treated with the control
ODN or PBS (p < 0.05). The lymphocyte counts on days 1
and 14 were not different from those in the control group.
The results indicate that intratracheal administration of
CpG-ODN induces neutrophil accumulation into the
alveolar space within 24 h, followed by lymphocyte accu-
mulation that lasts until 7 days after the CpG-ODN chal-
lenge.
Changes in Lung Permeability following Intratracheal 
CpG-ODN Administration
The permeability index was calculated as the BAL fluid-to-
plasma ratio of the concentration of human albumin that
was injected intravenously 1 hour before sacrifice (Figure
3). Thus, this index reflects pulmonary endothelial and
alveolar septal permeability. There was no difference in
the permeability index between the control animals and
those sacrificed 6 h after CpG-ODN instillation (0.043 ±
0.010% vs. 0.066 ± 0.013%, respectively). The permeabil-
ity index 24 h after the CpG-ODN challenge was as high
as 1.043 ± 0.269%, which was significantly greater than in
the other two groups (p < 0.01). These findings suggest
that CpG-ODN caused not only the inflammatory cell
accumulation, but also the increase in lung permeability.
Time course of total and differential cell counts in BAL fluid  after administration of 10 μM CpG-ODN Figure 2
Time course of total and differential cell counts in 
BAL fluid after administration of 10 μM CpG-ODN. 
(A) Total cell counts in BAL fluid were markedly increased 
24 h after CpG-ODN challenge and then decreased by 14 
days after the instillation. (B) Neutrophil counts on days 1 
and 2 were significantly greater than in the animals that 
received the control ODN or PBS. (C) Lymphocyte counts 
in BAL fluid were significantly increased on days 2 and 7 com-
pared with the mice treated with the control ODN or PBS. 
Values are the mean ± SEM; n = 5-6 for each group. *p < 0.05 
compared with the PBS group. †p < 0.05 compared with the 
control ODN group.Respiratory Research 2009, 10:84 http://respiratory-research.com/content/10/1/84
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Effects of Intratracheal CpG-ODN on Cytokine Levels in 
BAL Fluid and Plasma
BAL fluid and plasma were collected 6 h or 1, 2, or 7 days
after the intratracheal instillation, and the concentrations
of IL-1β, TNF-α, IL-6, IL-10, IL-12p40, IFN-γ, MIP-1α,
MIP-1β, MCP-1, and KC in the BAL fluid were measured.
As shown in Table 1, CpG-ODN instillation markedly
increased the levels of the pro-inflammatory cytokines
and chemokines in the alveolar space within 24 h. The
concentrations of most of the inflammatory mediators
measured were highest 24 h after the CpG-ODN chal-
lenge, except KC, which reached its peak 6 h after the
instillation. At 6 h, only KC, IL-1β, and IL-12p40 exhib-
ited significant increases compared with the mice that
received PBS or control ODN. The concentration of IL-10,
an anti-inflammatory cytokine, was highest 2 days after
the CpG-ODN administration. There were no significant
differences in the cytokine concentrations between the
mice with the control ODN instillation and those admin-
istered PBS.
In plasma, CpG-ODN also induced upregulation of IL-1β,
IL-6, IL-10, IL-12p40, KC, MCP-1, and MIP-1β, compared
with the animals receiving control ODN administration
(Table 2). The plasma level of IL-12p40 was significantly
elevated as early as 6 h after the CpG-ODN challenge. The
levels of other pro-inflammatory mediators in plasma
reached their peaks at 24 h, although the IL-10 level was
highest 48 h after the instillation, as was the case in BAL
fluid. Plasma cytokine levels returned to the baselines by
day 7. There were no significant differences in the plasma
cytokine concentrations at any time point between the
mice with the control ODN instillation and those admin-
istered PBS.
Histopathological Changes in the Lungs and Liver Induced 
by CpG-ODN
Representative microscopic findings of the H-E-stained
lung specimens are shown in Figure 4A. In the mice
treated with PBS or control ODN, no obvious neutrophil
recruitment was observed at 24 h after the intratracheal
instillation. The CpG-ODN challenge caused marked neu-
trophil accumulation in the alveolar space with thicken-
ing of the alveolar septa and areas of hemorrhage, which
is suggestive of acute lung injury.
Effect of intratracheal CpG-ODN challenge on the lung per- meability Figure 3
Effect of intratracheal CpG-ODN challenge on the 
lung permeability. The permeability index was calculated 
as the BAL fluid-to-plasma ratio of the concentration of 
human serum albumin injected intravenously 1 hour before 
sacrifice. CpG-ODN significantly increased the permeability 
index, which reached the peak 24 h after the instillation. Val-
ues are the mean ± SEM; n = 5-6 for each group and vehicle. 
*p < 0.05 compared with the PBS group. †p < 0.05 compared 
with the control ODN group.
Table 1: Cytokine levels in bronchoalveolar lavage fluid
CpG-ODN
PBS Control ODN 6 24 48 168 (h)
IL-1β 4.9 ± 2.1 3.4 ± 0.6 45.4 ± 3.0*† 56.7 ± 6.2*† 62.1 ± 8.0*† 12.0 ± 4.0
IL-10 3.0 ± 0.6 2.6 ± 0.4 5.1 ± 0.3 51.8 ± 12.2† 108.4 ± 23.1*† 2.6 ± 0.8
IFN-γ 2.8 ± 0.5 1.3 ± 0.3 2.0 ± 0.3 110.7 ± 38.1*† 39.9 ± 12.6 1.7 ± 0.3
TNF-α 41.2 ± 5.6 37.0 ± 1.9 75.1 ± 12.7 466.1 ± 184.1*† 153.8 ± 50.6 31.3 ± 2.5
IL-6 7.5 ± 1.7 3.5 ± 0.9 36.9 ± 8.8 150.0 ± 55.4*† 181.3 ± 69.0*† 3.2 ± 0.9
IL-12p40 15.3 ± 4.5 11.8 ± 1.6 396.9 ± 56.9*† 410.9 ± 57.8*† 453.1 ± 79.6*† 111.5 ± 45.8
KC 1.4 ± 0.3 2.0 ± 0.2 180.8 ± 38.5*† 75.0 ± 25.9 63.6 ± 16.4 2.4 ± 0.3
MCP-1 1.4 ± 0.4 1.6 ± 0.4 55.4 ± 20.7 965.9 ± 206.6*† 1295.7 ± 204.5*† 3.6 ± 2.5
MIP-1α 11.2 ± 1.4 3.6 ± 1.8 125.5 ± 50.7 321.6 ± 92.2*† 72.3 ± 15.6 4.1 ± 1.8
MIP-1β 1.6 ± 0.5 1.7 ± 0.3 17.6 ± 6.2 223.9 ± 16.0*† 158.9 ± 37.9*† 1.3 ± 0.3
All values (pg/mL) are expressed as the means ± SE (n = 5-6 in each group). *p < 0.05 was considered to be significantly different from the 
corresponding value of the PBS group. †p < 0.05 was considered to be significantly different from the corresponding value of the control ODN 
group.Respiratory Research 2009, 10:84 http://respiratory-research.com/content/10/1/84
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Since we observed elevated levels of inflammatory media-
tors in plasma, the liver was also subjected to histopathol-
ogy. As shown in Figure 4B, the livers from the mice,
which received CpG-ODN intratracheally, revealed
marked damage, including disruption of normal architec-
ture, necrosis, neutrophil infiltration, and hemorrhage.
The mice treated with PBS or control ODN showed nor-
mal liver lobular architecture and hepatocytes.
Effect of CpG-ODN on NF-κB DNA-binding Activity in the 
Lung
To evaluate the effect of CpG-ODN on the upregulation of
the NF-κB signaling pathway in the lung, nuclear extracts
of lung homogenates were analyzed using the TransAM™
ELISA kit. Because the most frequently activated form of
NF-κB in TLR signaling is a heterodimer composed of Rel
A(p65)-p50 [14] and p50 lacks the transcription activa-
tion domain, we used p65 as a marker of NF-κB activa-
tion. As shown in Figure 5, CpG-ODN challenge induced
high levels of NF-κB DNA-binding activity within 6 h,
which had been weakened to the baseline by day 2. Addi-
tionally, the binding was specific, since the wild-type con-
sensus oligonucleotide prevented NF-κB binding to the
probe immobilized on the plate; conversely, the mutated
oligonucleotide had no effects on NF-κB binding (data
not shown).
Discussion
In this study, we demonstrated that intratracheal adminis-
tration of CpG-ODN induces inflammatory cell accumu-
lation and permeability edema, as well as upregulation of
inflammatory mediators in the alveolar space. In addi-
tion, CpG-ODN challenge caused a systemic inflamma-
tory response characterized by hypercytokinemia and
liver damage. In contrast, control ODN without CpG
motif did not exert such pathological effects. These results
suggest that microbial DNA, which can be released during
antibiotic treatment, might contribute to not only the
development of ALI/ARDS but also the systemic inflam-
matory response following pneumonia. To the best of our
knowledge, this is the first report on the effect of intratra-
cheal administration of synthetic CpG-ODN on local and
systemic inflammatory responses.
Previous studies indicated that CpG-ODN enhances anti-
microbial immunity when it is administered systemically
or inhaled [15-17]. For example, Deng and colleagues
demonstrated that pretreatment with intratracheal CpG-
ODN improved survival after intratracheal inoculation of
Klebsiella [15]. On the other hand, it has been reported
that deleterious effects can occur when bacterial DNA or
CpG-ODN is administered in a systemic fashion [12,18].
Although compartmentalized delivery of CpG-ODN has
been reported to be well tolerated and protective against
respiratory pathogens, our results showed harmful effects
of intratracheal CpG-ODN. This discrepancy might be due
to the relatively larger amount (1.0 nmol) of CpG-ODN
used in the present study. Taken together, CpG-ODN,
which enhances host defense, may cause tissue injury
when administered in excess.
Neutrophils have been recognized as important contribu-
tors to the pathogenesis of ALI/ARDS [1,19]. In this study,
intratracheal administration of CpG-ODN induced
marked neutrophil influx into the alveolar space. In addi-
tion, the liver pathology showed neutrophil infiltration
with hemorrhage and necrosis at 24 h, suggesting that
upregulation of inflammatory mediators could have
occurred at an earlier time point. We observed that plasma
levels of KC and IL-12p40 were elevated 6 h after the CpG-
ODN challenge, whereas the levels of other mediators did
not differ from those in the mice treated with the control
ODN or PBS at the time point. In mice, KC or CXCL8 is
one of the most important chemokines for neutrophil
recruitment [20]. Since we observed markedly elevated KC
levels in BAL fluid as early as 6 h after the instillation of
Table 2: Cytokine levels in plasma
CpG-ODN
PBS Control ODN 6 24 48 168 (h)
IL-1β 34.7 ± 6.3 28.8 ± 6.6 47.6 ± 14.9 56.6 ± 5.6*† 42.4 ± 6.0*† 25.0 ± 4.4
IL-10 39.0 ± 0.6 33.5 ± 4.1 35.6 ± 13.0 95.2 ± 17.0 122.3 ± 18.5*† 46.1 ± 16.8
IFN-γ 2.3 ± 1.0 10.6 ± 4.3 1.7 ± 0.6 12.5 ± 4.8 4.2 ± 1.8 8.3 ± 7.5
TNF-α 759.0 ± 96.8 664.2 ± 78.0 550.3 ± 64.8 777.7 ± 83.0 690.8 ± 135.8 633.2 ± 74.0
IL-6 29.3 ± 18.8 14.1 ± 2.2 39.0 ± 7.0 124.3 ± 17.6*† 46.2 ± 9.3 12.7 ± 6.2
IL-12p40 126.0 ± 4.8 116.4 ± 10.9 314.5 ± 65.8*† 303.9 ± 20.9*† 235.8 ± 30.2 120.2 ± 12.4
KC 31.9 ± 4.9 32.0 ± 4.1 53.1 ± 13.4 92.7 ± 12.4*† 47.8 ± 9.8 23.2 ± 3.7
MCP-1 16.0 ± 5.7 4.6 ± 3.9 48.2 ± 27.0 137.1 ± 41.5*† 25.9 ± 9.5 13.6 ± 3.5
MIP-1α 31.5 ± 4.4 29.2 ± 3.4 25.5 ± 7.6 65.0 ± 8.9 42.0 ± 7.2 21.3 ± 11.2
MIP-1β 8.5 ± 2.5 6.3 ± 3.4 8.4 ± 3.4 23.6 ± 4.4† 10.7 ± 2.8 2.7 ± 1.3
All values (pg/mL) are expressed as the means ± SE (n = 5-6 in each group). *p < 0.05 was considered to be significantly different from the 
corresponding value of the PBS group. † p < 0.05 was considered to be significantly different from the corresponding value of the control ODN 
group.Respiratory Research 2009, 10:84 http://respiratory-research.com/content/10/1/84
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CpG-ODN, KC might be a key mediator that promoted
neutrophil accumulation into the lung. In addition,
plasma KC levels were elevated at 24 h, suggesting that KC
might contribute to further neutrophil recruitment into
the lungs and liver. Stefanovic and Stefanovic reported
that KC overexpression causes massive liver necrosis
within 2 days and KC induces immediate expression of
proinflammatory genes [21]. We concluded that KC
might play a central role in the pulmonary and systemic
inflammation following CpG-ODN challenge.
IL-12, a crucial cytokine for DC-mediated induction of
Th1 cell differentiation, is also known as a T cell stimulat-
ing factor, which stimulates the production of IFN-γ and
TNF-α from T and natural killer cells. It was previously
reported that CpG-DNA stimulation resulted in pro-
longed NF-κB activity at the IL-12p40 promoter and IL-
12p40 production by hepatic DCs [22,23]. In addition,
Tanaka and colleagues reported that anti-IL-12 mAb
blocked  Propionibacterium acnes and LPS-induced liver
injury and concluded that IL-12 may be an essential
cytokine in the course of T cell-dependent liver injury
[24]. In the present study, IL-12p40 was the only mediator
that was elevated in plasma as early as 6 h. We believe that
CpG-ODN stimulation might induce the production of
IL-12, which could play a key role in the development of
the liver injury.
We previously reported that LPS-induced pulmonary
responses can be augmented by mononuclear cell phago-
cytosis in the reticuloendothelial system (RES) [25]. The
activated RES might contribute to the further upregulation
of inflammatory mediators. It remains to be determined
whether, at the later time points, plasma inflammatory
mediators are released from the alveolar space or RES in
the liver or spleen.
There are two possible mechanisms for the remote liver
damage we observed. One is that the liver damage was
caused by inflammatory mediators that leaked or were
released from the alveolar space. The other is that the
injury was caused directly by CpG-ODN that entered the
Representative histopathological findings of the lungs and the liver after CpG-ODN challenge Figure 4
Representative histopathological findings of the lungs and the liver after CpG-ODN challenge. (A) CpG-ODN 
challenge caused numerous neutrophil accumulation in the alveolar space with thickening of the alveolar septa and areas of 
hemorrhage. (B) Intratracheal CpG-ODN induced marked liver damage, including disruption of normal architecture, necrosis, 
neutrophil infiltration, and hemorrhage. Original magnification × 100.Respiratory Research 2009, 10:84 http://respiratory-research.com/content/10/1/84
Page 8 of 9
(page number not for citation purposes)
blood stream from the lungs. Slotta and coworkers
reported that intraperitoneal injection of CpG-ODN
caused liver injury on day 1, which was characterized by
sinusoidal leukostasis, deterioration of the microcircula-
tion, and hepatocyte apoptosis [26]. Considering the
molecular size of CpG-ODN (2.6 kDa), we speculated
that CpG-ODN could travel through the epithelial and
endothelial barriers of the lung into the blood stream.
Severe pneumonia is known to be one of the major risk
factors for the development of ALI/ARDS [1]. It was also
reported that ALI/ARDS can develop even though appro-
priate antibiotics are administered to treat the pneumonia
[27]. When bacteria are killed by antibiotics, the bacterial
cell component or its fragments are released into the sur-
rounding environment, such as blood or alveolar epithe-
lial lining fluid. It is widely known that cell wall
components, such as LPS and peptidoglycan, can cause
acute lung injury via the TLR4 and TLR 2 signaling path-
ways, respectively [6]. The results of our study indicate
that microbial DNA could also contribute to the patho-
genesis of tissue injury. The pathogen-associated molecu-
lar pattern of unmethylated bacterial DNA is recognized
by TLR9, and its immunomodulatory effects can be mim-
icked by ODNs containing unmethylated CpG motifs
[4,5]. Upon recognition of CpG-rich sequences in the
endosome, TLR9, expressed by B cells, macrophages, and
dendritic cells (DCs), initiates a conserved TLR family sig-
naling cascade that begins with the recruitment of the
adaptor protein MyD88, resulting in NF-κB translocation
to the nucleus [28]. CpG-induced NF-κB activation initi-
ates the up-regulation of costimulatory molecules and the
secretion of proinflammatory cytokines, such as TNF-α
and IL-6. Since we observed significant NF-κB activation
as well as up-regulation of inflammatory cytokines fol-
lowing CpG administration, this pathway could be
responsible for the development of pulmonary and sys-
temic inflammation.
It may be difficult to extrapolate the present data to clini-
cal settings, partly because the number or frequency of
CpG motifs in a genome is varied between the types of
organisms. In addition, the local concentration of CpG-
ODN is determined by not only the bacterial burden but
also the amount of the fluid in the airspace. For example,
a pneumonic patient with dehydration, who has lesser
amount of the exudate and shows modest infiltration on
the chest roentgenogram, may have concentrated CpG-
ODN in the airspace.
The major limitation of this study is that it still remains
unclear whether or not various inflammatory events after
the CpG-ODN challenge are truly TLR9-dependent. Sev-
eral reports have described TLR9-independent recognition
of bacterial DNA [29,30]. For instance, transfection with
bacterial double stranded DNA activates macrophages
and DCs to produce TNF in a TLR9-independent manner
[29]. In addition, DAI-1, previously named DLM-1 or Z-
DNA binding protein 1, has been identified as a cytoplas-
mic receptor that senses and is activated by DNA, leading
to type I IFN gene induction [31]. The mechanisms of
CpG-ODN-induced pulmonary and systemic inflamma-
tory processes should be the subject of future investiga-
tion.
Conclusion
Intratracheal administration of CpG-ODN induced
inflammatory cell accumulation and permeability edema
of the lung as well as cytokinemia and inflammatory
change in the liver. It is concluded that microbial DNA
could cause lung injury with systemic inflammation.
Among various microbe-derived products, we may have
to consider not only cell wall components such as LPS,
but also gene fragments as a key material and therapeutic
target to prevent ALI/ARDS following pneumonia.
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